Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VYTORIN
- High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
- Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
- Anti-inflammatory Effects of Simvastatin
- Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
- A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
- Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
- Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy
- Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coro
- Vascular and Metabolic Effects of Vytorin vs Simvastatin
- Vascular and Metabolic Effects of Vytorin
- A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)
- Vytorin in the Treatment of Alopecia Areata
- Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
- To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects
- Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
- Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
- Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647)
- Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction
- Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
- Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
- Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
- Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
- Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
- Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
- Vytorin on Carotid Intima-media Thickness and Overall Rigidity
- Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)
- Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
- Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)
- Comprehensive Magnetic Resonance of Peripheral Arterial Disease
- A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
- Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
- Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
- A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
- Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
- Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe
- Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
- Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)
- Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)
- Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
- IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)
- Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
Clinical trials list
click for details